Benjamin Li
Nov 2, 2010

APCO appoints Pui-Shan Lee as Shanghai VP

SHANGHAI - APCO Worldwide has appointed Pui-shan Lee, former executive director at Citigate Dewe Rogerson, as vice-president based in Shanghai.

Pui-Shan Lee
Pui-Shan Lee

Lee (pictured) brings a wealth of experience in advising companies and multinationals in financial communication. At Citigate, Lee devised public relations strategies for a wide range of Chinese companies' overseas initial public offerings.

Her previous clients included Bank of Communications, China Pacific Insurance, Baosteel and China Life, Industrial and Commercial Bank of China.

Prior to Citigate, Lee was the financial editor at Television Broadcasts Limited, where she oversaw a team of 20 reporters and managed the financial newscast production. She also covered the banking and capital markets as a reporter for the Hong Kong Economic Journal.

"With Hong Kong as a key international finance center and Shanghai as the financial hub of China, there is a need to help Chinese clients with financial communication within these two cities, particularly as they continue to seek global growth," Lee said. "I look forward to working with APCO's global financial communications team."

Joining APCO alongside Lee is Sukyi Yau, who lead APCO's financial communication practice in Asia last summer and is a principal in the firm's global practice.

Source:
Campaign China

Related Articles

Just Published

3 hours ago

Agency Report Card 2023: Accenture Song

The tech-powered creative unit of Accenture has continued its aggressive growth strategy with a number of new acquisitions, but it remains to be seen whether that growth can be sustained long term.

4 hours ago

Group M goes global with AI adtech partner

Partnership brings ‘intelligent creative’ to Group M’s global clients.

4 hours ago

Roblox makes video ads available to all advertisers

By partnering with Integral Ad Science and Kantar, the game platform also now offers measurement solutions for advertisers on Roblox.

4 hours ago

Pharma’s corporate reputation begins to slide ...

The pharma industry’s Covid-peak in corporate reputation has begun to drop, though it still remains higher than pre-pandemic levels.